抑郁症致病机制及中药治疗抑郁症的机制研究

姚媛; 周艺; 周婷婷

doi:10.3969/j.issn.1006-0111.2018.03.001

抑郁症致病机制及中药治疗抑郁症的机制研究

doi: 10.3969/j.issn.1006-0111.2018.03.001

1.
安徽中医药大学药学院, 安徽合肥 230012;第二军医大学药学院, 上海 200433;上海市药物(中药)代谢产物研究重点实验室, 上海 200433
2.
94826部队医院内科, 上海 200433
3.
第二军医大学药学院, 上海 200433;上海市药物(中药)代谢产物研究重点实验室, 上海 200433

基金项目: 国家自然科学基金资助项目（81573584，81773862）

Pathogenesis of depression and the mechanism research in TCM treatment of major depression

1.
School of Pharmacy, Anhui University of Chinese Medicine, Hefei 230012, China;School of Pharmacy, Second Military Medical University, Shanghai 200433, China;Shanghai Key Laboratory for Pharmaceutical Metabolites Research, Shanghai 200433, China
2.
Medical Department of 94826 Military Hospital, Shanghai 200433, China
3.
School of Pharmacy, Second Military Medical University, Shanghai 200433, China;Shanghai Key Laboratory for Pharmaceutical Metabolites Research, Shanghai 200433, China

摘要: 抑郁症严重危害人类身心健康，世界卫生组织预测：2020年抑郁症将成为非正常死亡和残疾的第二大原因。目前临床上大多使用三环类抗抑郁药（TCA）、四环类抗抑郁药、选择性5-HT再摄取抑制药等来治疗抑郁症，但长期应用这类药物易产生耐药性，不良反应明显，且这种通过单一成分阻断特定单一靶点的药物，对于涉及体内多个系统的生物学异常往往难以达到治疗效果。中药组方通过其所包含的多组分能同时调节多靶点、调节疾病网络的多个环节，在获得较高疗效的同时可降低化学药单靶点引起的毒副作用，且目前国内外对一些传统中药抗抑郁作用机制的研究报道也日渐增多，主要集中在神经递质水平释放、海马脑源性神经营养因子（BDNF）表达及细胞因子等方面。此外，最新的研究认为肠道菌群可能参与了从情感性疾病到神经系统疾病的发生发展。综述近年来中药抗抑郁神经保护作用的机制研究进展，以期为抑郁症发病机制探讨及抗抑郁药物研究提供借鉴和指导。
- 中药 /
- 抑郁症 /
- 机制 /
- 神经营养因子 /
- 炎症介质 /
- 脑-肠-微生物轴
Abstract: Depression is a serious health hazard and the World Health Organization predicts that depression will be the second leading cause of abnormal death and disability by 2020. Currently, most antidepressants are tricyclic antidepressants (TCA), tetracyclic antidepressants and selective 5-HT reuptake inhibitors. Long term use of those medications will develop resistance and adverse reactions. In addition, drugs that block a single target are often hard to achieve therapeutic outcomes due to the biological abnormalities involving multiple systems in the body. Traditional Chinese Medicine (TCM) can simultaneously act on multiple targets to influence the disease network in many aspects at the same time. This approach has higher efficacy and lower side effects than a single chemical medication. Recently, there are increasing numbers of research papers on antidepressant mechanism of TMC, mainly focused on the release level of neurotransmitters, hippocampus brain derived neurotrophic factor (BDNF) expression and cytokines, etc. The latest researches also indicated that the gut microbiota has involved the development of emotional diseases and the diseases related to central nerves system. This paper reviews the mechanism studies of TMC as antidepressants and neuroprotection agents in order to shed new light on the study of depression pathogenesis and development of new antidepressant medications.
- Traditional Chinese Medicine /
- depression /
- mechanism /
- neurotrophic factor /
- inflammatory mediators /
- microbiota-gut-brain axis

[1]	Sayers J. The world health report 2001-Mental health:new understanding,new hope[J]. Bullet World Health Organ,2001,79(11):1085.
[2]	Zhang X, Tian JS, Liu H, et al. Progress of new antidepressant drugs development[J]. Chin J Chin Mater Medic, 2017, 42(1):29-33.
[3]	王旭东, 乔明琦, 张樟进,等. 中医药治疗抑郁症的研究进展[J]. 南京中医药大学学报, 2016, 32(1):93-96.
[4]	Adam Samuels B, Leonardo ED, Hen R. Hippocampal subfields and major depressive disorder[J]. Biol Psychiatry, 2015, 77(3):210-211.
[5]	Schoenfeld TJ, Mccausland HC, Morris HD, et al. Stress and loss of adult nurogenesis differentially reduce hippocampal volume[J]. Bioll Psychiatry, 2017,82(12):914-923.
[6]	Hill AS, Sahay A, Hen R. Increasing adult hippocampal neurogenesis is sufficient to reduce anxiety and depression-like behaviors[J]. Neuropsychopharmacology, 2015, 40(10):2368-2378.
[7]	Bremner JD, Narayan M, Anderson ER, et al. Hippocampal volume reduction in major depression[J]. Am J Psychiatry, 2000, 157(1):115-118.
[8]	Moraitis AG, Block T, Nguyen D, et al. The role of glucocorticoid receptors in metabolic syndrome and psychiatric illness[J]. J Steroid Biochem Mol Biol, 2017, 165:114-120.
[9]	张国双, 杨坤. 抗抑郁新靶点-糖皮质激素受体[J]. 国际精神病学杂志, 2015,42(1):84-86.
[10]	Kinlein SA, Wilson CD, Karatsoreos IN. Dysregulated hypothalamic-pituitary-adrenal axis function contributes to altered endocrine and neurobehavioral responses to acute stress[J]. Front Psychiatry, 2015, 6:31.
[11]	Ferrari F, Villa RF. The neurobiology of depression:an integrated overview from biological theories to clinical evidence[J]. Mol Neurobiol,2017,54(7):4847-4865.
[12]	乔卉, 安书成, 徐畅. BDNF与抑郁症的研究现状及进展[J]. 生理科学进展, 2011, 42(3):195-200.
[13]	Rantamaki T, Yalcin I. Antidepressant drug action-from rapid changes on network function to network rewiring[J]. Prog Neuropsychopharmacol Biol Psychiatry, 2016, 64:285-292.
[14]	Schmitt K, Holsboer-Trachsler E, Eckert A. BDNF in sleep, insomnia, and sleep deprivation[J]. Ann Med, 2016, 48(1-2):42-51.
[15]	Hauser SR, Getachew B, Taylor RE, et al. Alcohol induced depressive-like behavior is associated with a reduction in hippocampal BDNF[J]. Pharmacol Biochem Behav, 2011, 100(2):253-258.
[16]	Zhuang F, Zhou X, Gao X, et al. Cytokines and glucocorticoid receptors are associated with the antidepressant-like effect of alarin[J]. Peptides, 2016, 76:115-129.
[17]	Felger JC, Lotrich FE. Inflammatory cytokines in depression:neurobiological mechanisms and therapeutic implications[J]. Neuroscience, 2013, 246(5):199-229.
[18]	Su WJ, Cao ZY, Jiang CL. Inflammatory mechanism of depression and its new strategy for diagnosis and treatment[J].Sheng Li Xue Bao,2017,69(5):715-722.
[19]	汪崇泽, 盛国红. 免疫炎症途径与抑郁症的研究进展[J]. 精神医学杂志, 2015,28(5):397-400.
[20]	Zhu X, Han Y, Du J, et al. Microbiota-gut-brain axis and the central nervous system[J]. Oncotarget, 2017, 8(32):53829-53838.
[21]	于林, 胡号应, 丁国安,等. 肠道微生物在抑郁症发病中的作用及其研究进展[C].2016中华中医药学会神志病分会学术年会,2016.
[22]	Zheng P, Zeng B, Zhou C, et al. Gut microbiome remodeling induces depressive-like behaviors through a pathway mediated by the host's metabolism[J]. Mol Psychiatry, 2016, 21(6):786-796.
[23]	Zhang QX,Ma XL,Yang Y, et al. Jieyuanshen decoction exerts antidepressant effects on depressive rat model via regulating hpa axis and the level of amino acids neurotransmitter[J]. Afric J Tradit,Complement Altern Med,2017, 14(2):33-46.
[24]	刘婉婉, 许璐, 董宪喆,等. 开心散类方对慢性应激大鼠行为学及中枢单胺类神经递质的影响[J]. 中国中药杂志, 2015, 40(11):2180-2185.
[25]	Dong XZ, Li ZL, Zheng XL, et al. A representative prescription for emotional disease, Ding-Zhi-Xiao-Wan restores 5-HT system deficit through interfering the synthesis and transshipment in chronic mild stress-induced depressive rats[J]. J Ethnopharmacol, 2013, 150(3):1053-1061.
[26]	Gong MJ, Han B, Wang SM, et al. Icariin reverses corticosterone-induced depression-like behavior, decrease in hippocampal brain-derived neurotrophic factor (BDNF) and metabolic network disturbances revealed by NMR-based metabonomics in rats[J]. J Pharm Biomed Anal, 2016, 123:63-73.
[27]	Ye YL,Zhong K, Liu DD, et al. Huanglian-Jie-Du-Tang extract ameliorates depression-like behaviors through BDNF-TrkB-CREB pathway in rats with chronic unpredictable stress[J]. Evidence-Based Complement Altern Med,2017(4):1-13.
[28]	Chen CY, Yeh YW, Kuo SC, et al. Differences in immunomodulatory properties between venlafaxine and paroxetine in patients with major depressive disorder[J]. Psychoneuroendocrinology, 2017, 87:108-118.
[29]	An L, Li J,Yu ST, et al. Effects of the total flavonoid extract of Xiao bu xin-Tang on depression-like behavior induced by lipopolysaccharide and proinflammatory cytokine levels in mice[J]. J Ethnopharmacol, 2015, 163:83-87.
[30]	Qiu JJ, Liu Z, Zhao P, et al. Gut microbial diversity analysis using Illumina sequencing for functional dyspepsia with liver depression-spleen deficiency syndrome and the interventional Xiaoyaosan in a rat model[J]. World J Gastroenterol, 2017, 23(5):810-816.

[1]	向兴, 张慧卿, 张琪金, 刘银沁, 黄宝康. 飞机草中医药文献研究及其中药性能探讨 . 药学实践与服务, 2025, 43(4): 195-199. doi: 10.12206/j.issn.2097-2024.202410019
[2]	赵文萃, 赵庆兰, 吴艳云, 徐萍, 王莹. 白及复方补脾中药的质量标准研究 . 药学实践与服务, 2025, 43(11): 564-566, 576. doi: 10.12206/j.issn.2097-2024.202303040
[3]	潘宇炯, 何志高, 周昕, 黄乾元. 医院中药软膏的粒度情况研究 . 药学实践与服务, 2025, 43(10): 519-524. doi: 10.12206/j.issn.2097-2024.202309019
[4]	辛海量, 蒋益萍, 韩婷, 郭涛, 年华, 岳小强. 中药香囊质量规范研究 . 药学实践与服务, 2025, 43(): 1-4. doi: 10.12206/j.issn.2097-2024.202402004
[5]	刘梦肖, 陈林林, 王彦, 张俊平. 中药苦参的研究进展 . 药学实践与服务, 2025, 43(4): 156-162. doi: 10.12206/j.issn.2097-2024.202406053
[6]	陶宫佳, 陈林林, 宋泽成, 刘梦肖, 王彦. 苦参碱及衍生物的抗炎作用及其机制研究进展 . 药学实践与服务, 2025, 43(4): 163-168, 194. doi: 10.12206/j.issn.2097-2024.202406035
[7]	王晓丹, 刘文杰, 宋畅, 董文星, 赵倩, 马骁龙. 利多卡因凝胶贴膏联合普瑞巴林治疗带状疱疹后神经痛患者疗效及对血清疼痛介质的影响 . 药学实践与服务, 2025, 43(11): 572-576. doi: 10.12206/j.issn.2097-2024.202505036
[8]	曹金发, 钟玲, 何苗, 田泾. 1例炎症性肠病合并心房颤动患者的用药分析与监护 . 药学实践与服务, 2025, 43(10): 525-528. doi: 10.12206/j.issn.2097-2024.202403004
[9]	游飘雪, 陈兰, 施艺玮, 王辉, 晁亮, 洪战英. 脑胶质瘤微流控芯片模型的构建及中药半枝莲药效评价应用研究 . 药学实践与服务, 2025, 43(2): 59-66. doi: 10.12206/j.issn.2097-2024.202409034
[10]	于永菊, 何敏. 高校大学生生命意义感的演变模式及其与抑郁症状的关联 . 药学实践与服务, 2025, 43(): 1-7. doi: 10.12206/j.issn.2097-2024.20240380
[11]	肖农, 陆诗依, 唐文雅, 居敏俐, 徐刚锋, 杨明华. 中成药微生物计数法前处理的影响因素和优化方法 . 药学实践与服务, 2025, 43(8): 373-376, 409. doi: 10.12206/j.issn.2097-2024.202403014
[12]	张紫璇, 高苑, 张利, 李佳莉, 徐希科, 祖先鹏. 中药防治急性肺损伤的活性成分及其作用机制研究进展 . 药学实践与服务, 2025, 43(9): 421-426, 474. doi: 10.12206/j.issn.2097-2024.202404079
[13]	吴海韵, 杨甜, 张弛, 梁文仪, 苏娟. 气相色谱-离子迁移谱技术在中药研究中的应用进展 . 药学实践与服务, 2025, 43(): 1-6. doi: 10.12206/j.issn.2097-2024.202409007
[14]	段雅倩, 段然, 林美玉, 刘畅, 苏娟. 热分析法在中药中的应用进展 . 药学实践与服务, 2025, 43(10): 475-480, 508. doi: 10.12206/j.issn.2097-2024.202506033
[15]	陈莹, 许子华, 胡北, 崔亚玲, 高欢, 吴琼. 通便灵胶囊治疗便秘的药效与机制研究 . 药学实践与服务, 2025, 43(1): 10-16. doi: 10.12206/j.issn.2097-2024.202404008
[16]	刘彬果, 吴葆婷, 王剑丽, 陈竹卿. 中药防治流感病毒性肺炎的作用及机制研究进展 . 药学实践与服务, 2025, 43(11): 540-547. doi: 10.12206/j.issn.2097-2024.202402033
[17]	赖立勇, 夏天爽, 徐圣焱, 蒋益萍, 岳小强, 辛海量. 中药青蒿抗氧化活性的谱效关系研究 . 药学实践与服务, 2024, 42(5): 203-210, 216. doi: 10.12206/j.issn.2097-2024.202211012
[18]	景凯, 杨慈荣, 张圳, 臧艺蓓, 刘霞. 黄芪甲苷衍生物治疗慢性心力衰竭小鼠的药效评价及作用机制研究 . 药学实践与服务, 2024, 42(5): 190-197. doi: 10.12206/j.issn.2097-2024.202310004
[19]	钱淑雨, 李铁军. 耐碳青霉烯类肠杆菌耐药机制的研究进展 . 药学实践与服务, 2024, 42(10): 419-425. doi: 10.12206/j.issn.2097-2024.202405005
[20]	岳春华, 贲永光, 王海桥. 基于NLRP1炎症小体探讨百合知母汤抗抑郁的作用机制 . 药学实践与服务, 2024, 42(8): 325-333. doi: 10.12206/j.issn.2097-2024.202401033

点击查看大图

计量

文章访问数: 7956
HTML全文浏览量: 1208
PDF下载量: 935
被引次数: 0

姓名
邮箱
手机号码
标题
留言内容
验证码

留言板

抑郁症致病机制及中药治疗抑郁症的机制研究

doi: 10.3969/j.issn.1006-0111.2018.03.001

Pathogenesis of depression and the mechanism research in TCM treatment of major depression

计量

抑郁症致病机制及中药治疗抑郁症的机制研究

doi: 10.3969/j.issn.1006-0111.2018.03.001

English Abstract

Pathogenesis of depression and the mechanism research in TCM treatment of major depression

全文HTML

目录

留言板

抑郁症致病机制及中药治疗抑郁症的机制研究

doi: 10.3969/j.issn.1006-0111.2018.03.001

Pathogenesis of depression and the mechanism research in TCM treatment of major depression

计量

出版历程

抑郁症致病机制及中药治疗抑郁症的机制研究

doi: 10.3969/j.issn.1006-0111.2018.03.001

English Abstract

Pathogenesis of depression and the mechanism research in TCM treatment of major depression

全文HTML

目录